✦ LIBER ✦

Increasing the number of drugs in antiretroviral therapy may improve survival in people with HIV infection

✍ Scribed by George W. Rutherford

Book ID: 111725099
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 73 KB
Volume: 6
Category: Article
ISSN: 1462-9410
DOI: 10.1054/ebhc.2002.0542

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antiretroviral Therapy in HIV-Infected C

Antiretroviral Therapy in HIV-Infected Children: The Metabolic Cost of Improved Survival

✍ Leonard, Ethan G.; McComsey, Grace A. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 279 KB

Antiretroviral therapy improves survival

Antiretroviral therapy improves survival in patients with HIV and multi-drug resistant tuberculosis

✍ N. Padayatchi; S. Abdool Karim; K. Naidoo; A. Grobler; T. Gengiah; G. Friedland 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 84 KB

Does use of antiretroviral therapy regim

Does use of antiretroviral therapy regimens with high central nervous system penetration improve survival in HIV-infected adults?

✍ H McManus; PCK Li; D Nolan; M Bloch; S Kiertiburanakul; JY Choi; B Mulhall; K Pe 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB

Do people with HIV infection have a norm

Do people with HIV infection have a normal life expectancy in the era of combination antiretroviral therapy?

✍ Sabin, Caroline A 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 201 KB

Occurrence of Opportunistic Infections i

Occurrence of Opportunistic Infections in People Living with HIV/AIDS Following Antiretroviral Therapy in West Bengal, India

✍ Sayan Chakraborty; Mehebubar Rahman; Bibhuti Saha 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 85 KB

Overcoming resistance to existing therap

Overcoming resistance to existing therapies in HIV-infected patients: The role of new antiretroviral drugs

✍ Carlo-Federico Perno; Graeme Moyle; Chris Tsoukas; Winai Ratanasuwan; Jose Gatel 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB

## Abstract Resistance to available antiretroviral (ARV) agents is of increasing concern, and development of novel agents that address this problem has been identified as a major public health priority. As ARV resistance becomes more prevalent with extended use of existing agents, individuals with